Biodesix (BDSX) Return on Capital Employed (2020 - 2026)

Biodesix (BDSX) has 7 years of Return on Capital Employed data on file, last reported at 32.57% in Q1 2026.

• Quarterly Return on Capital Employed rose 901.0% year-over-year to 32.57% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 32.57% (up 901.0% YoY) and the FY2025 annual result came in at 37.2%, up 394.0% from the prior year.
• Return on Capital Employed rose to 32.57% in Q1 2026, from 39.44% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 32.57% in Q1 2026 to a low of 152.13% in Q3 2022.
• A 5-year average of 73.29% and a median of 58.12% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 11512 bps — and 2024, when it surged 6155 bps.
• Tracing BDSX's Return on Capital Employed over 5 years: stood at 91.62% in 2022, then increased by 24 bps to 69.45% in 2023, then surged by 42 bps to 40.27% in 2024, then increased by 2 bps to 39.44% in 2025, then rose by 17 bps to 32.57% in 2026.
• The last three Return on Capital Employed figures came in at 32.57% (Q1 2026), 39.44% (Q4 2025), and 46.45% (Q3 2025), per Business Quant data.